Cabergoline (Australian Online Pharmacy Information Guide)

Cabergoline is a medicine used to treat certain hormone-related conditions, most commonly those involving high levels of prolactin (a hormone produced by the pituitary gland). It works by mimicking the effects of dopamine, helping to reduce prolactin levels and (in some cases) shrink hormone-producing pituitary tumours.

This guide is designed to be patient-friendly and to help you understand how cabergoline works, how it is typically taken, and what to consider regarding food, alcohol, interactions, safety, and availability in Australia.

Basic product information

How cabergoline works (mechanism of action)

Cabergoline belongs to a group of medicines called dopamine receptor agonists. It primarily stimulates dopamine receptors in the brain and pituitary gland.

• Reduces prolactin release: Prolactin production is normally inhibited by dopamine. Cabergoline strengthens this dopamine effect, leading to lower prolactin levels.
• Helps shrink prolactin-secreting pituitary tumours: In many patients with prolactin-producing adenomas, lowering prolactin can also reduce tumour size over time.
• May improve symptoms: Lower prolactin can help restore reproductive hormone balance, improving symptoms such as irregular periods, infertility, breast milk leakage (galactorrhoea), and sometimes symptoms caused by tumour pressure (e.g., headaches or visual disturbances).

Pharmacokinetics (how the body handles it)

“Pharmacokinetics” describes what happens to a medicine after you take it: absorption, distribution, metabolism, and elimination.

• Absorption: Cabergoline is absorbed after oral administration and reaches peak levels in the body typically within a few hours (exact timing can vary by formulation and individual factors).
• Distribution: It has a long-lasting effect partly because it stays active in the body for an extended period.
• Metabolism: Cabergoline is metabolised in the liver (primarily through enzymatic pathways). This can be relevant for interactions with other medicines that affect liver enzymes.
• Elimination: The medicine and its metabolites are removed from the body mainly via bile/faeces and to a smaller extent via urine.
• Long duration of action: Even though dosing may occur less frequently, cabergoline’s effects can last because of its long persistence in the body.

Typical uses (indications)

Cabergoline is used when prolactin levels are too high or when a pituitary tumour produces prolactin. Common indications may include:

• Hyperprolactinaemia (elevated prolactin) causing symptoms
• Prolactin-secreting pituitary adenomas (prolactinoma)
• Galactorrhoea (inappropriate breast milk production) linked to high prolactin
• Menstrual irregularities and fertility issues related to hyperprolactinaemia
• Hypogonadism associated with high prolactin
• Other specialist uses may exist in selected clinical scenarios depending on local practice and patient factors

Important note: Indications can vary by product registration and local guidance. Your clinician will decide the most appropriate use based on diagnosis, symptom severity, and monitoring needs.

Dosing overview: how it’s usually taken

Cabergoline dosing schedules vary depending on the condition and patient response. Some regimens use weekly dosing, often starting low and gradually increasing if needed.

General dosing principles

• Start low, go slow: Many clinicians begin with a low dose to reduce side effects such as nausea or light-headedness.
• Adjust based on response: The dose may be adjusted to reach target prolactin levels and symptom improvement.
• Use a consistent schedule: If you are taking it weekly, try to keep the day and time consistent.
• Do not change your dose: Only change the dose if advised by your healthcare professional.

Timing within the day

Because cabergoline can affect blood pressure and cause dizziness in some people, many patients take it when they can rest afterwards. Follow your clinician’s instructions and consider taking it at a time that suits you (for example, evenings), especially during dose initiation.

Missed dose guidance

If you miss a dose, take it when you remember unless it is close to the next scheduled dose. Do not double up. For the most accurate advice, refer to your product information and your healthcare professional.

When to take cabergoline: practical timing tips

• Morning vs night: If you feel dizzy after taking cabergoline, consider asking your healthcare professional whether evening dosing could be more suitable.
• Be cautious when standing up: On start or after dose changes, rise slowly from sitting or lying positions to reduce dizziness.
• Keep a dosing reminder: Weekly regimens can be easier when you use a calendar, phone reminder, or pharmacy blister pack.
• Monitoring appointments: Plan blood tests and follow-up imaging (if applicable) as recommended.

Food interactions and dietary considerations

Food may influence how some medicines are absorbed or tolerated, though cabergoline’s key determinants are its absorption and metabolism. In practice:

• Take with food if it upsets your stomach: If nausea occurs, taking cabergoline with a meal may help.
• Consistency matters: Try to take it the same way each time (with or without food), unless advised otherwise.
• Hydration: Staying well-hydrated can help reduce symptoms related to low blood pressure.

If you have specific dietary needs (e.g., due to other medical conditions), ask your pharmacist to review your full medication plan.

Alcohol and medicine interactions

Alcohol can worsen side effects such as dizziness, drowsiness, and nausea. It may also increase the chance of falls or feeling faint—especially at the start of treatment or after dose increases.

• General advice: Limit alcohol and avoid drinking if you notice light-headedness or fatigue after cabergoline.
• Driving and machinery: If you feel sleepy or dizzy, do not drive or operate machinery.

Other medicine interactions to consider

Cabergoline can interact with several medicines, including:

• Antipsychotics and some other dopamine antagonists may reduce cabergoline’s effectiveness.
• Some blood pressure medicines may increase the risk of low blood pressure symptoms.
• Medicines that affect liver enzymes may alter cabergoline levels.
• Other medicines that cause sleepiness can increase sedation risks when combined.

Always provide your pharmacist and clinician with a full list of medicines, vitamins, and herbal products you use.

Safety profile and side effects

Like all medicines, cabergoline can cause side effects. Many are mild and improve over time, particularly after the first dose or dose increases.

Common side effects

• Nausea or stomach upset
• Dizziness or light-headedness
• Headache
• Fatigue or weakness
• Constipation
• Dry mouth
• Low blood pressure symptoms, such as feeling faint when standing

Seek medical attention urgently if you experience

• Severe or persistent fainting
• Chest pain, shortness of breath, or new swelling of the legs
• Severe allergic reaction symptoms (e.g., facial swelling, breathing difficulty, widespread rash)

Rare but important warnings

• Impulse control and compulsive behaviours: Dopamine agonists can, in some cases, cause behaviours such as compulsive gambling, shopping, eating, or other urges. Tell your healthcare professional if you or your family notice unusual changes in behaviour.
• Sleepiness: Some patients may experience sleepiness or sudden sleep episodes. Avoid driving and operating machinery if you feel unusually drowsy.
• Heart valve concerns (especially long-term/high exposure): Reports have raised concerns about valve changes with long-term use of some dopamine agonists. Risk is influenced by dose and duration, and monitoring may be recommended in certain patients.
• Psychiatric effects: Mood changes can occur. Seek advice promptly if you notice significant changes.

Safety monitoring: what your care team may check

Depending on your diagnosis and dose, your clinician may recommend:

• Regular prolactin blood tests to confirm response
• Evaluation of symptoms (e.g., menstrual regularity, galactorrhoea, headaches/vision)
• Imaging (e.g., MRI of the pituitary) if indicated
• Blood pressure monitoring if you’re prone to dizziness or hypotension
• Heart assessment in selected long-term cases, especially if higher exposure is used

Practical use tips (patient-friendly checklist)

• Use a consistent routine: Keep the same weekly day/time if your regimen is weekly.
• Start carefully: If you’re just beginning or increasing the dose, plan for a lower-activity day in case you feel dizzy or nauseated.
• Get up slowly: This helps prevent “orthostatic” symptoms (light-headedness when standing).
• Keep track of side effects: Note when symptoms occur (after which dose, how severe, how long) and share this with your healthcare professional.
• Don’t stop suddenly: Abrupt discontinuation can lead to prolactin levels rising again. Always consult your clinician for changes.
• Attend follow-ups: Monitoring improves safety and helps ensure the medicine is working.

Alternative options for hyperprolactinaemia

Depending on the cause of elevated prolactin and your individual situation, alternatives may include:

• Other dopamine agonists (commonly used in prolactin-related conditions):
  • Quinagolide (where available)
  • Bromocriptine (where appropriate)
• Surgery for certain pituitary tumours or when medication is not suitable (specialist decision)
• Radiation therapy in selected long-term tumour management plans
• Address underlying causes where prolactin elevation is due to other factors (e.g., medication-induced changes, thyroid issues)

Which option is best depends on tumour size, prolactin levels, tolerance to dopamine agonists, fertility goals, and monitoring requirements.

Cabergoline in Australia: market and legal context

In Australia, medicines are supplied under the national framework administered through Therapeutic Goods Administration (TGA) processes, including regulatory approval and listing.

• Medicine status: Cabergoline-containing products may be supplied through prescription-based pathways and are governed by Australian medicines scheduling rules.
• Brand and strength availability: Specific brands and tablet strengths available to patients can vary over time.
• Safety requirements: Product information and Australian guidance influence monitoring recommendations and patient counselling.

For the most accurate information about current supply, product strengths, and pharmacy availability, contact your Australian pharmacy or check the product details provided on the listing page.

Recent guidance and clinical considerations (what patients should know)

Clinical practice for prolactin-related conditions continues to evolve, particularly around long-term safety monitoring.

• Heart valve monitoring attention: Increasing emphasis has been placed on assessing valve risk in patients receiving long-term dopamine agonists, especially at higher cumulative exposure.
• Behavioural and sleepiness warnings: Patient education has become more prominent to help detect rare impulse-control and somnolence problems early.
• Individualised dosing: Clinicians frequently aim for the lowest effective dose that controls prolactin while minimising side effects.
• Structured follow-up: Ongoing monitoring of prolactin and symptom response remains central to safe long-term use.

Tip: If you start noticing new symptoms after weeks or months on treatment (e.g., breathlessness, swelling, unusual urges), report them promptly.

Delivery and availability in Australia

Availability of cabergoline tablets can depend on current stock levels, brand choice, and strength. Many online pharmacies in Australia can deliver to eligible postcodes using standard delivery services, and sometimes faster options may be available.

• Stock checks: Listings may update based on supply.
• Packaging: Medicines are typically supplied in manufacturer packaging with clear labelling and patient information.
• Delivery timeframes: Delivery speed can vary depending on location and carrier.
• Cold chain: Cabergoline is usually not temperature-sensitive in the way that some biologics are, but always store as directed on the label.

If you’re unsure about whether cabergoline is currently available in the strength you need, use the “contact us” or “ask a pharmacist” option on the website listing.

Storage and handling

• Store tablets as directed on the label (commonly at controlled room temperature).
• Keep out of reach of children.
• Protect from moisture and avoid storing in bathrooms unless the label says it’s suitable.
• Do not use after expiry date.

FAQ: Cabergoline (Australia)

1) What is cabergoline used for?

Cabergoline is mainly used to treat conditions where prolactin is too high, such as hyperprolactinaemia and prolactin-secreting pituitary adenomas (prolactinomas). It helps lower prolactin and may improve symptoms such as irregular periods, fertility issues, and galactorrhoea.

2) How often do I take cabergoline?

Many regimens use weekly dosing, often starting with a low dose and adjusting over time. Your exact schedule depends on your diagnosis and response.

3) Can I take cabergoline with food?

Yes—taking with food can help if you experience nausea. If you tolerate it well, follow the same routine each time for consistency. Always follow the instructions on the product information or given by your clinician.

4) Will cabergoline make me dizzy?

Dizziness or light-headedness can occur, particularly at the start or after dose changes, due to effects on blood pressure. Rise slowly from sitting or lying positions and avoid driving if you feel unsteady.

5) Is it safe to drink alcohol while on cabergoline?

Alcohol may increase dizziness, drowsiness, and nausea. It’s best to limit alcohol and avoid it if you notice side effects after taking cabergoline. If you have concerns, speak with a pharmacist.

6) What medications can interact with cabergoline?

Interactions may occur with antipsychotics (dopamine antagonists), medicines that lower blood pressure, medicines that affect liver enzymes, and drugs that cause drowsiness. Provide your full medication list to your pharmacist for a tailored interaction check.

7) What side effects are most common?

Common side effects include nausea, dizziness, headache, fatigue, and constipation. Most are mild and may lessen with time or slower dose titration.

8) Are there any rare but serious risks?

Yes. Cabergoline can, rarely, be associated with impulse-control problems and sleepiness. There are also concerns about heart valve changes with long-term use in some patients (risk depends on dose and duration). Seek medical advice promptly if you experience concerning symptoms such as breathlessness, chest pain, fainting, or unusual urges.

9) How long does it take to work?

Prolactin levels may start to fall relatively quickly, but symptom improvement and tumour shrinkage (if applicable) often take weeks to months. Follow-up blood tests and clinical review guide how well the medicine is working.

10) What should I do if I miss a dose?

If you miss a dose, take it when you remember unless it is close to the next scheduled dose. Do not double up. For your specific weekly schedule, follow the guidance from the product information and your healthcare professional.

11) Are there alternatives if I can’t tolerate cabergoline?

Depending on the situation, clinicians may consider other dopamine agonists (such as quinagolide or bromocriptine where appropriate) or other strategies like surgery or addressing underlying causes of elevated prolactin.

12) Does cabergoline affect fertility?

By lowering prolactin, cabergoline may restore normal reproductive hormone function and improve fertility in some people. If you are trying to conceive or considering pregnancy, discuss planning and monitoring with your healthcare team.

When to contact a pharmacist or healthcare professional

Contact your healthcare professional promptly if you experience:

• Fainting, severe dizziness, or symptoms suggesting very low blood pressure
• New shortness of breath, chest pain, persistent swelling, or worsening fatigue
• Unusual behavioural urges (e.g., compulsive gambling/shopping/eating)
• Allergic symptoms such as rash, swelling, or breathing difficulty

For personalised advice about dosing, interactions, and monitoring in Australia, your pharmacist can help you review your medicine plan and side-effect prevention strategies.